GSK3B and Alzheimer disease: We further showed that TDZD-8 antagonized AD-like pathological characteristics by preventing NAP1L5 knockdown-mediated toxic effects, indicating that NAP1L5 regulated AD-like pathological characteristics by regulation of the GSK3B/Wnt/β-Catenin signaling pathway.